Distribution and functionality of the somatostatin receptor subtypes in acromegaly.
Saveanu
A
A
Interactions Cellulaires Neuroendocriniennes, UMR6544-CNRS-Université de la Méditerranée, Institut Fédératif Jean Roche, Faculté de Médecine Nord, Marseille, France.
Gunz
G
G
Dufour
H
H
Enjalbert
A
A
Culler
M D
MD
Jaquet
P
P
D000172:Acromegaly / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D000236:Adenoma / Q000188:drug therapy / Q000378:metabolism*; D000818:Animals; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D019382:Human Growth Hormone / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D051379:Mice; D015282:Octreotide / Q000627:therapeutic use; D010456:Peptides, Cyclic / Q000627:therapeutic use; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D015175:Prolactinoma / Q000188:drug therapy; D051381:Rats; D017481:Receptors, Somatostatin / Q000145:classification / Q000378:metabolism*; D013004:Somatostatin / Q000031:analogs & derivatives / Q000627:therapeutic use
D018931:Antineoplastic Agents, Hormonal; D010456:Peptides, Cyclic; D017481:Receptors, Somatostatin; C060347:lanreotide; D019382:Human Growth Hormone; D013004:Somatostatin; D015282:Octreotide